Determination of the Microelement Composition of Biopsy Material of Red Bone Marrow in Patients with Hemoblastoses by the SR–XRF Method

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Personalized medicine is a modern concept aimed at individualization of patient therapy. The relevance of the search and identification of new highly sensitive and specific prognostic markers in patients with hemoblastoses is due to the leading positions in the incidence and mortality rate among young working-age population, which gives the problem special socio-economic significance. The study is aimed at studying the content of trace elements in biopsy material (red bone marrow) of patients with hemoblastoses at the onset of the disease and after chemoradiation therapy. Using the method of X-ray fluorescence analysis and synchrotron radiation, it is possible to simultaneously determine more than 25 chemical elements in a low-mass sample with non-destructive sample preparation. Difference in the concentrations of 10 elements (S, K, Ca, Cu, Zn, Fe, Se, Br, Rb, Cd) in patients with two pathologies, lymphoma and leukemia, is considered.

全文:

受限制的访问

作者简介

V. Trunova

Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University

编辑信件的主要联系方式.
Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk

T. Pospelova

Novosibirsk State Medical University

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk

M. Voytko

Novosibirsk State Medical University

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk

E. Krupovich

Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences; Institute of Catalysis of the Siberian Branch of the Russian Academy of Sciences

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk; Koltsovo

G. Soldatova

Novosibirsk State Medical University; Novosibirsk State University

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk

R. Kuzmin

Novosibirsk State Medical University

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk

K. Tsigulyov

Novosibirsk State Medical University

Email: valna-t@mail.ru
俄罗斯联邦, Novosibirsk

参考

  1. Овечкина В.Н., Бондаренко С.Н., Морозова Е.В. и др. // Клиническая онкогематология. 2017. T. 10 № 3. C. 351. http://doi/org/10.21320/2500-2139-2017-10-3-351-357
  2. Schmid C., Labopin M., Nagler A., Niederwieser D., Castagna L., Tabrizi R., Stadler M., Kuball J., Cornelissen J., Vorlicek J., Socié G., Falda M., Vindeløv L., Ljungman P., Jackson G., Kröger N., Rank A., Polge E., Rocha V., Mohty M. // Blood. 2012. V. 119. № 6. P. 1599. http://doi/org/10.1182/blood-2011-08-375840
  3. Christopeit M., Kuss O., Finke J. et al. // J. Clin. Oncol. 2010. V. 31. № 26. P. 3259. http://doi/org/10.1200/JCO.2012.44.7961
  4. Kröger N., Bornhäuser M., Stelljes M., Pichlmeier U., Trenschel R., Schmid C., Arnold R., Martin H., Heinzelmann M., Wolschke C., Meyer R. G., Bethge W., Kobbe G., Ayuk F., Gökbuget N., Hölzer D., Zander A., Beelen D. // Bone Marrow Transplant. 2014. V. 50. № 12. P. 1503. http://doi/org/10.1038/bmt.2015.202
  5. Каприн А.Д., Старинский А.В., Шахзадовой А.О. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П.А. Герцена, 2022. 239 с.
  6. Мирзаахмедова И.З. // Экономика и социум. 2022. Т. 3. № 2. С. 94.
  7. Мамедова А.А., Мочкин Н.Е., Саржевский В.О. и др. // Онкогематология. 2022. Т. 17. № 3. С. 40. http://doi/org/10.17650/1818-8346-2022-17-3-40-47
  8. Савченко В.Г., Паровичникова Е.Н., Афанасьев Б.В. // Гематология и трансфузиология. 2018. Т. 63. № 1-S2. С. 5.
  9. Azin F., Raie R.M., Mahmoudi M.M. // Ecotoxicology and Environmental Safety. 1998. V. 39. № 3. P. 179.
  10. Guidotti T.L., McNamara J., Moses M.S. // Indian J. Med. Res. 2008. V. 128. № 4. P. 524.
  11. Cui Y., Vogt S., Olson N., Glass A.G., Rohan T.E. // Cancer Epidemiol. Biomarkers Prevention. 2007. V. 16. № 8. P. 1682.
  12. Yelinova V., Glazachev Y., Khramtsov V., Kudryashova L., Rykova V., Salganik R. // Biochem. Biophys. Res. Commun. 1996. V. 221. № 2. P. 300.
  13. Ohanian M., Telouk P., Kornblau S., Albarede F., Ruvolo Peter, Tidwell R.S., Plesa A., Kangal-Shamanna R., Matera E., Cortes J., Carson A., Dumontet Ch. // Am. J. Hematology. 2020. V. 95. № 4. P. 422. http://doi/org/10.1002/ajh.25731
  14. Kul A. N., Ozturk Kurt B. // Clinical and Experimental Medicine. 2024. V. 24. № 1. P. 1. http://doi/org/10.1007/s10238-024-01349-5
  15. Qayyum M.A., Shah M.H. // Biol. Trace Elem. Res. 2020. V. 194. № 1. P. 34. http://doi/org/10.1007/s12011-019-01746-y
  16. Hasegawa T., InagakI K., Haraguchi H. // Analyt. Sci. 2001. V. 17. P. 979.
  17. Cirovic A., Cirovic A. // Leukemia Res. 2022. V. 112. Р. 106755. http://doi/org/10.1016/j.leukres.2021.106755
  18. Ehudin M.A., Golla U., Trivedi D., Potlakayala S.D., Rudrabhatla S.V., Desai D., Dovat S., Claxton D., Sharma A. // Int. J. Mol. Sci. 2022. V. 23. Р. 7972. http://doi/org/10.3390/ijms23147972
  19. Chrysochou E., Koukoulakis K., Kanellopoulos P.G., Sakellari A., Karavoltsos S., Dassenakis M., Minaidis M., Maropoulos G., Bakeas E. // J. Trace Elements Medicine Biol. 2021. V. 68. Р. 126833. http://doi/org/10.1016/j.jtemb.2021.126833
  20. Schmitt Y., Schneider H. // Nephrology Dialysis Transplantation. 1993. V. 8. № 5. P. 438.

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Incidence and mortality rates of patients with haemoblastosis from 2018 to 2023.

下载 (179KB)
索引源数据
3. Fig. 2. Study design. NHL - non-Hodgkin's lymphoma, PCT - polychemotherapy.

下载 (534KB)
索引源数据
4. Fig. 3. Results of elemental analysis of red bone marrow of leukaemia patients: 1 - before polychemotherapy; 2 - after the first course; 3 - after the second course.

下载 (312KB)
索引源数据
5. Fig. 4. Results of elemental analysis of red bone marrow of patients with lymphoma: 1 - before polychemotherapy; 2 - after the first course; 3 - after the second course.

下载 (289KB)
索引源数据

版权所有 © Russian Academy of Sciences, 2025